Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 600-028-9 | CAS number: 1001254-87-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
No acute toxicity tests are available for the inhalation route of exposure. A data waiver is claimed.
Cyclohexane, 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethyl-, homopolymer, acetone oxime-blocked is of low oral and dermal acute toxicity with an oral LD50 (rat) of > 2000 mg/kg bw (Hüls AG, 1998) and a dermal LD50 (rat) of > 2000 mg/kg bw (LPT, 2012).
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1998-02-16 to 1998-03-05
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 (Acute Toxicity (Oral))
- GLP compliance:
- yes
- Test type:
- acute toxic class method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ORGANISMS:
- Strain: Cpb/Win:WU (SPF)
- Source: Harlan Winkelmann GmbH, Borchen (Germany)
- healthy, young adult animals
- Controls: no
- Fasting period before study: 16 hours
- Diet: ad libitum, R10 special diet for rats, SSniff R
- Water: ad libitum, tab water
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 3 °C
- Humidity (%): 30 - 70 %
- Photoperiod (hrs dark / hrs light): 12 hours artificial light, 12 hours dark
- Air changes (per hr): 15 per hour - Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on oral exposure:
- ADMINISTRATION:
- test compound was grinded and suspended in corn oil
- 20 g/100ml
- Doses per time period: single dose (gavage)
- Volume administered : 10 ml/kg bw - Doses:
- 2000 mg/kg bw
- No. of animals per sex per dose:
- 3
- Control animals:
- no
- Details on study design:
- EXAMINATIONS:
- Mortality, clinical signs: soon after dosing and at frequent intervals for day 0, than once daily for next 2 weeks
- Body weights: days 0, 7, and 14
- Post dose observation period: 14 days
- Macroscopic examination: directly after exitus (animal that died) / day 14 (surviving animals) - Statistics:
- not required
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No deaths occurred.
- Clinical signs:
- other: No signs of systemic reaction to treatment.
- Gross pathology:
- NECROPSY FINDINGS: Macroscopical examination revealed no abnormalities.
- Other findings:
- no other findings
- Conclusions:
- According to this study the LD50 value (oral) was estimated to be > 2000 mg/kg bw in rats for the test item.
- Executive summary:
In an acute oral toxicity study (limit test) according OECD 401 a single dose of 2000 mg/kg test item was applied to three male and female Wistar rats.
The observation period was 14 days.
There were no deaths and no signs of systemic reaction to treatment, body weight development was normal.
Macroscopical examination revealed no abnormalities at the end of the observation period.
Under conditions of this study the LD50 value (oral) is above 2000 mg/kg bw in Wistar rats.
Reference
no further remarks
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- The study is valid without restriction (Klimisch score 1).
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
- Quality of whole database:
- According to REACH Annex VIII (Column 2 of section 8.5.3) acute inhalation study is not needed, because inhalation of the substance is unlikely during use or/and production and skin contact is considered to be the relevant route of exposure during use or/and production.
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2011-09-26 to 2011-10-24
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Version / remarks:
- 1987
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.1200 (Acute Dermal Toxicity)
- Version / remarks:
- 1998
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.3 (Acute Toxicity (Dermal))
- Version / remarks:
- 2008
- GLP compliance:
- yes
- Test type:
- fixed dose procedure
- Limit test:
- yes
- Species:
- rat
- Strain:
- other: Rattus norvegicus
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- - Strain: Rattus norvegicus CD / Crl: CD(SD)
- Sex, age and body weight range
5 males, 8 weeks old, 200 - 213 g
5 females, 9 weeks old, 200 - 220 g
- Controls: no
- Fasting period before study: 16 hours
- Diet: ad libitum, R10 special diet for rats, SSniff R
- Water: ad libitum, tab water
- Acclimation period: at least 5 days
- Housing: during the 14-day observation period animals were kept singly in MAKROLON cages (type III plus)
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 3 °C
- Humidity (%): 55 +/- 15 %
- Photoperiod (hrs dark / hrs light): 12 hours artificial light, 12 hours dark
- Air changes (per hr): 15 per hour - Type of coverage:
- occlusive
- Vehicle:
- water
- Details on dermal exposure:
- - Method of administration:
The intact dorsal skin of the animals was shaved free of hair with a shaver . The site was situated on the animal´s back between the fore and hind
extremities and had an area of at least 5 cm x 6 cm (approx. 1/10 of body surface).
The test patch was occlusive. The test item was held in contact with the skin with 8 layers of gauze. The gauze was covered with a plastic sheet and
secured with adhesive plaster strips on the application site for 24 hours. - Duration of exposure:
- 24 hours
- Doses:
- - 2000 mg/kg bw,
- administration volume 10 ml/kg bw - No. of animals per sex per dose:
- 5
- Control animals:
- not required
- Details on study design:
- EXAMINATIONS:
- Clinical signs: before and immediately, 5, 15, 30 and 60 min, as well as 3, 6 and 24 hours after administration
- Mortality: at least once daily
- Body weights: days 0, 7, and 14
- Post dose observation period: 14 days
- Macroscopic examination: day 14 - Statistics:
- not required
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Remarks on result:
- other: no mortalities
- Mortality:
- No mortality was observed at 2000 mg/kg
- Clinical signs:
- other: No clinical signs were observed.
- Gross pathology:
- Macroscopic examination did not reveal any changes.
- Other findings:
- No other findings
- Conclusions:
- Based on the results of this study the dermal LD50 of test item was estimated to be > 2000 mg/kg in male and female rats.
- Executive summary:
In this experiment the test item was examined for acute toxicity after a single dermal application to rats.
One dose level of 2000 mg/kg b.w. was employed (limit test).
Under the present test conditions, a single dermal application of 2000 mg test item/kg b.w. to rats did not reveal any clinical signs of toxicity. No influence on animal behaviour or premature death was noted. The body weight gain was not influenced by the test item administration. No skin reactions were observed at the application site.The macroscopic examination did not reveal any changes.
Based on the results of this study the dermal LD50 of test item was > 2000 mg/kg in male and female rats.
Reference
No further information
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- The study is valid without restriction (Klimisch score 1).
Additional information
No acute toxicity tests are available for the inhalation route of exposure. A data waiver is claimed. Cyclohexane, 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethyl-, homopolymer, acetone oxime-blocked is of low oral and dermal acute toxicity with an oral LD50 (rat) of > 2000 mg/kg bw (Hüls AG, 1998) and a dermal LD50 (rat) of > 2000 mg/kg bw (LPT, 2012).
Justification for selection of acute toxicity – oral endpoint
Only one study available.
Justification for selection of acute toxicity – dermal endpoint
Only one study available.
Justification for classification or non-classification
Based on the results of the acute oral and dermal studies and according to the criteria of EC Regulation 1272/2008 cyclohexane, 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethyl-, homopolymer, acetone oxime-blocked has a very low acute toxicity if swallowed or if it comes in contact with skin. Therefore, the test substance must not be classified.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
